Neurobehavioral & Cognitive Disorders
Progressive subcortical gliosis
May. 14, 2024
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Worddefinition
At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas.
02.27.2023
People who regularly use laxatives, a common treatment for constipation, may have more than a 50% increased risk of developing dementia than people who do not use laxatives, according to a study published in the February 22, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. Researchers also found people who used only osmotic laxatives, a type of laxative that attracts water to the colon to soften stool, had an even greater risk. Other types of laxatives are bulk-forming, stool-softening, and stimulating. The study does not prove that laxatives cause dementia. It only shows an association.
“Constipation and laxative use are common among middle-aged and older adults,” said study author Feng Sha PhD, of the Shenzhen Institute of Advanced Technology at the Chinese Academy of Sciences in Guangdong, China. “However, regular laxative use may change the microbiome of the gut, possibly affecting nerve signaling from the gut to the brain or increasing the production of intestinal toxins that may affect the brain. Our research found regular use of over-the-counter laxatives was associated with a higher risk of dementia, particularly in people who used multiple laxative types or osmotic laxatives.”
Sha noted that osmotic and stimulant laxatives are not recommended for regular use, yet some people use them regularly.
The study involved 502,229 people in the UK biobank database with an average age of 57 who did not have dementia at the start of the study. Of this group, 18,235 people, or 3.6%, reported regularly using over-the-counter laxatives. Regular use was defined as using a laxative most days of the week during the month before the study.
Over an average of 10 years, 218 of those who regularly used laxatives, or 1.3%, developed dementia. Of those who did not regularly use laxatives, 1,969 people, or 0.4%, developed dementia.
After adjusting for factors such as age, sex, education, other illnesses and medication use, and a family history of dementia, researchers found people who regularly used laxatives had a 51% increased risk of overall dementia compared to people who did not regularly use laxatives.
The risk of dementia also increased with the number of laxative types used. For people using one type of laxative, there was a 28% increased risk, compared to a 90% increased risk for people taking two or more types of laxatives.
However, among people using only one type, only those taking osmotic laxatives had a heightened risk, with a 64% increase compared to those who did not use laxatives.
“Finding ways to reduce a person’s risk of dementia by identifying risk factors that can be modified is crucial,” said Sha. “More research is needed to further investigate the link our research found between laxatives and dementia. If our findings are confirmed, medical professionals could encourage people to treat constipation by making lifestyle changes such as drinking more water, increasing dietary fiber and adding more activity into their daily lives.”
A limitation of the study is that dosage information for laxatives was not available so researchers could not explore the relationship between various laxative dosages and dementia.
The study was funded by the National Natural Science Foundation of China, Shenzhen Science and Technology Program and the Chinese Academy of Sciences.
Source: News Release
American Academy of Neurology
February 22, 2023
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125